Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a **combination product** containing seawater, sodium thiosulfate pentahydrate, and sodium hyaluronate. - **Seawater** is commonly used as an isotonic or hypertonic diluent in nasal or ophthalmic products to flush, hydrate, or cleanse mucosal surfaces but has no pharmacologically specific activity. - **Sodium thiosulfate pentahydrate** is an inorganic compound best known for its use as an antidote in cyanide poisoning, as well as treatment for calciphylaxis and to reduce cisplatin-induced ototoxicity, primarily through its sulfur-donating, detoxifying, anti-calcification, antioxidant, and anti-inflammatory effects. Its mechanism involves providing sulfur for detoxification and chelation[1][3][4]. - **Sodium hyaluronate** is the sodium salt of hyaluronic acid, widely used for lubrication, moisturizing, and as a wound-healing adjunct in ophthalmic, dermatologic, and joint products; it binds and retains water, forming a viscoelastic protective film. This specific combination may be formulated for topical, ophthalmic, or mucosal administration, aiming to combine osmoprotective, detoxifying, anti-inflammatory, and lubricating actions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on seawater + sodium thiosulfate pentahydrate + sodium hyaluronate.